ENDOPEPTIDASE/ANTI-PSMA ANTIBODY FUSION PROTEINS FOR TREATMENT OF CANCER

Details for Australian Patent Application No. 2002312226 (hide)

Owner CORNELL RESEARCH FOUNDATION, INC.

Inventors NANUS, David, M.; RUOQIAN, Shen; BANDER, Neil

Pub. Number AU-A-2002312226

PCT Number PCT/US02/17298

PCT Pub. Number WO2002/096460

Priority 60/294,359 30.05.01 US

Filing date 30 May 2002

Wipo publication date 9 December 2002

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 009/48 Enzymes, e.g. ligases (6.) - acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 016/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/294,359 30.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002312226

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312227-APPARATUS AND METHOD FOR CONTROLLING THE OPERATING WAVELENGTH OF A LASER

2002312225-REVERSE-MODE DIRECT-VIEW DISPLAY EMPLOYING A LIQUID CRYSTAL HAVING A NON-VISIBLE CHARACTERISTIC WAVELENGTH